Human neutrophils treated with chemotactic peptides or phorbol esters demonstrate tyrosine phosphorylation of a subset of proteins. Granulocyte-macrophage colony-stimulating factor (GM-CSF) induced a time-and concentrationdependent increase in the tyrosine phosphorylation of at least seven proteins. Three of these proteins with approximate molecular weights of 150,95, and 70 Kd were unique t o neutrophils treated with OM-CSF, and were not seen t o be phosphorylated on tyrosine in neutrophils treated with the agonists FMLP or PMA, or the cytokines G-CSF and tumor necrosis factor. We found the 150-Kd protein t o be localized within the cell particulate fraction and the 95-Kd protein within the cell cytosol. The 70-Kd phosphotyrosine protein was found in both fractions. When the neutrophils were treated with Triton X-100 (Sigma Chemical Co, St Louis, MO) to evaluate cytoskeletal associations of proteins, the 150 UMAN NEUTROPHILS are nonproliferating circu-H lating phagocytes that can be activated by a variety of ligands to release granule contents, reduce molecular oxygen to superoxide anion, aggregate, and to chemotax.lJ The biochemical basis for these processes are not known, but have been linked to the posttranslational phosphorylation of specific proteins by protein kinase^.^-^ We have previously reported that neutrophils possess a membrane-associated phosphotyrosine phosphatase activity' and distinct tyrosine kinase activities in the cell cytosol and a detergent extracted particulate fraction.8 Furthermore, we found that activation of human neutrophils with the chemotactic peptide formyl-methionyl-leucyl-phenylalanine (FMLP) as well as the phorbol ester, phorbol myristate acetate (PMA), induces the phosphorylation of specific proteins on tyrosine residues9 and increases the activity of the cytosolic and particulate-associated tyrosine kinases.1° Inhibition of the neutrophil tyrosine kinases inhibited some, but not all, neutrophil activation events9 These data indicate that tyrosine phosphorylation may be involved in the biochemical control of neutrophil responses to stimuli.
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We have previously reported that neutrophils possess a membrane-associated phosphotyrosine phosphatase activity' and distinct tyrosine kinase activities in the cell cytosol and a detergent extracted particulate fraction.8 Furthermore, we found that activation of human neutrophils with the chemotactic peptide formyl-methionyl-leucyl-phenylalanine (FMLP) as well as the phorbol ester, phorbol myristate acetate (PMA), induces the phosphorylation of specific proteins on tyrosine residues9 and increases the activity of the cytosolic and particulate-associated tyrosine kinases.1° Inhibition of the neutrophil tyrosine kinases inhibited some, but not all, neutrophil activation events9 These data indicate that tyrosine phosphorylation may be involved in the biochemical control of neutrophil responses to stimuli.
Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a hematopoietic growth factor that is produced by a wide variety of cell types." The gene for GM-CSF has been cloned" and human GM-CSF is available as a recombinant protein that is now being used in humans to augment phosphotyrosine protein partitioned with the Triton X-100 insoluble cytoskeleton (TICS), and the 70-Kd protein partitioned with both the TICS and Triton X-100 soluble proteins. The GM-CSF-induced tyrosine phosphorylation was inhibited by the tyrosine kinase inhibitor ST638. This was not seen with the putative C-kinase inhibitor, H-7. However, staurosporine was seen t o inhibit tyrosine phosphorylation of neutrophil proteins by GM-CSF and in vitro tyrosine kinase activity of isolated neutrophil cytosol and particulate fractions. These data indicate that the three unique GM-CSF-induced phosphotyrosine-containing proteins may be responsible for the unique actions of GM-CSF and that staurosporine inhibits a tyrosine kinase responsible for the phosphorylation of these proteins. 0 1992 by The American Society of Hematology.
neutrophil production in patients receiving myelosuppressive chemotherapy.12 When neutrophils are treated in vitro with GM-CSF the cells are inhibited in their directed movement, become more adherent, alter their expression of receptors for chemotactic peptides, and increase synthesis of nuclear proteins related to cell On the addition of a second activating stimulus, neutrophils undergo an enhanced response with increased superoxide production, and leukotriene B, ~ynthesis.ll,l~,~~-*~ This latter indirect effect of GM-CSF is termed "priming." Although the biochemical basis of neutrophil priming by GM-CSF has not been clearly elucidated, this cytokine has been shown to induce tyrosine phosphorylation in the myeloid cell line M07E." GM-CSF has also been reported to induce tyrosine phosphorylation of several neutrophil proteins, as demonstrated using a polyclonal antiphosphotyrosine a n t i b~d y .~~~~ These reports suggested that phosphorylation of proteins on tyrosine residues by GM-CSF may play a role in its action on human neutrophils.
In this paper we report that (1) treatment of human neutrophils with GM-CSF induces the phosphorylation of a number of proteins on tyrosine residues; (2) at least three of these phosphotyrosine-containing proteins are unique to cells stimulated with GM-CSF; (3) several of these unique tyrosine phosphorylated proteins are associated with the Triton X-100 insoluble cytoskeleton; (4) the GM-CSFinduced tyrosine phosphorylation of neutrophil proteins is inhibited by the tyrosine kinase inhibitor ST638 as well as the putative C-kinase inhibitor Staurosporine; and (5) Staurosporine inhibits the neutrophil tyrosine kinase activities in vitro. suspended at a density of 1 x 107/mL in phosphate-buffered saline (PBS), pH 7.4, containing 1 mmol/L CaCl,, 1 mmol/L MgS04, and 5.5 mmol/L glucose. The cells were greater than 98% neutrophils and were greater than 99% viable by trypan blue exclusion.
MATERIALS AND METHODS

Materials
Detection of neutmphilproteinsphosphotylated on tyrosine residues. Neutrophils at 1 x 107/mL were prewarmed to 37°C for 5 minutes and then stimulated with the agonist indicated in the text and figure legends. The reaction was allowed to proceed for the specified time and terminated by the rapid addition of an equal volume of "stop buffer," containing 20% trichloracetic acid (TCA), 1 mmol/L phenylmethylsulfonyl fluoride (PMSF), 7 pg/mL aprotinin and pepstatin, 2 mmol/L N-ethylmaleimide (NEM), 100 mmol/L NaF, and 5 mmol/L diisopropyl-fluorophosphate (DFP). After 60 minutes at 4"C, the protein pellet was washed three times with ice-cold acetone, solubilized in SDS lysis buffer,28 and heated to 100°C for 5 minutes.
In experiments where neutrophil cytosol and particulate fractions were evaluated, the reaction was stopped with equal volumes of ice-cold PBS, pH 7.4, containing 2 mmol/L NEM, 1 mmol/L vanadate, 1 mmol/L PMSF, 10 mmol/L EDTA, 7 pg/mL of pepstatin and leupeptin, 100 mmol/L NaF, and 5 mmol/L DFP. After 10 minutes at 4"C, the cells were centrifuged at 50% and sonicated in a buffer containing 20 mmol/L HEPES, pH 7.5, 100 pmol/L vanadate (to inhibit phosphotyrosine phosphatase), 2 mmol/L PMSF, 2 mmol/L 2-mercaptoethanol, and 7 pg/mL of leupeptin and pepstatin. In some experiments, 2 mmol/L EDTA and 2 mmol/L NEM was added to fully prevent kinase activity during fractionation. The sonicate was centrifuged at 5oOg for 5 minutes to remove unbroken cells and cell nuclei and then at 50, OOOg for 60 minutes at 4°C. The 50,ooOg supernatant (cytosol) was mixed with an equal volume of TCA stop buffer, and the 50,OOOg pellet (particulate) was resuspended in sonication buffer and then in an equal volume of TCA stop buffer. The proteins were then handled as above.
To isolate the Triton X-100 insoluble cytoskeleton of treated neutrophils, the cells were incubated with the agonist indicated in the text, and the reaction was stopped with an equal volume of "lysis buffer" containing 2% Triton X-100, 20 mmol/L imidazole, 80 mmol/L KCl, and 20 mmol/L EGTA, 5 mmol/L DFP, and 100 pmol/L vanadate, pH 7.15 as modified from Howard and Ores a j~.~~ After 10 minutes at 25°C the cells were centrifuged at 13,OOOg and the supernatant removed (Triton X-100 soluble supernatant, TSS). Protein was isolated from TSS by the addition of an equal volume of 20% TCA stop buffer, and processed as above. The pellet (Triton insoluble cytoskeleton, TICS) was solubilized in SDS lysis buffer, and boiled at 100°C for 5 minutes.
Separation of the neutrophil proteins was by SDS polyacrylamide gel electrophoresis (PAGE). The proteins were then transferred to nitrocellulose according to the method described by B~r n e t t e .~~
The nitrocellulose filter was then incubated in Tris 10 mmol/L pH 7.3, NaCl 150 mmol/L, and sodium azide 0.01% (TNA) containing 3% bovine serum albumin (BSA) from 4 to 24 hours. The proteins were then probed with 1 kg/mL of a monoclonal antiphosphotyrosine antibody (PY-20) at 25°C for 2 hours. The filter was washed five times in TNA containing 0.1% NP-40 and then incubated with antimouse IgG labeled with 1251. The filter was again washed five times and dried, and autoradiography done at -70°C for variable times using Kodak XAR film (Eastman
Cell isolation.
Kodak, Rochester, NY). The approximate molecular mass of the phosphotyrosine-containing proteins was determined using a log plot of the migration of molecular weight standards. In the experiments shown, some variation in the control level of tyrosine phosphorylation was noted depending on the blood donor used. Similarly, in some experiments, autoradiography was prolonged in an attempt to demonstrate minor bands.
In some experiments phenylphosphate or phosphotyrosine was added to the PY-20 antiphosphotyrosine antibody to block the binding of the antibody to the neutrophil proteins.
Phosphorylation of a synthetic copolymer of glutamine:tyrosine, (4:1)", by neutrophil proteins was determined by our previously described method. 6 The reaction volume of 250 pL contained 20 mmol/L HEPES at pH 7.5, 10 mmol/L MgCl,, 10 mmol/L MnC12, 100 pmol/L sodium orthovanadate, 7 mg/mL p-nitrophenyl phosphate (as a competitive substrate for phosphotyrosine phosphatases), 1 to 20 kg of cell protein, 1 mg of copolymer, and 8 pmol/L ATP (2,000 to 4,000 cpm/pmol of [Y-~~PIATP). The reaction was begun by the addition of cell protein and allowed to proceed for 5 minutes at 30°C. The reaction was stopped by the addition of 2 mL of ice-cold 20% TCA, and the proteins allowed to precipitate for 60 minutes. The samples were then filtered on Gelman GN-6 filters (Gelman Sciences, Ann Arbor, MI) and washed with 10 mL (2 mL x 5) of 5% TCA containing 10 mmol/L sodium pyrophosphate. The filters were placed in vials, 5 mL of Filtron-X (National Diagnostics, Manville, NJ) was added and the sample counted for radioactivity. To determine specific tyrosine phosphotransferase activity, the amount of 32P incorporation in the absence of copolymer was subtracted from the amount of 32P incorporated in the presence of copolymer.
Tyrosine kinase assay.
RESULTS
When human neutrophils in suspension are treated with GM-CSF for periods from 30 to 120 minutes they become "primed" for an enhanced respiratory burst to the chemotactic peptide FMLP.13J9,20,21 The reasons for this prolonged "priming" time are unknown. For biochemical alterations to be considered possible second messengers they must precede the observed physiologic response. Previous reports have shown that the pattern of GM-CSFinduced tyrosine phosphorylation of proteins in neutrophils, as detected using polyclonal antiphosphotyrosine antibodies, are similar to those seen when FMLP was used as the stimulus. 24 We have previously reported that when a monoclonal antiphosphotyrosine antibody (PY-69) was used to assess phosphotyrosine patterns in stimulated human neutrophils, a somewhat different pattern of phosphotyrosine-containing proteins was seen compared with that reported by others9 Therefore, we treated neutrophils with 200 pmol/L GM-CSF for variable times and assessed tyrosine phosphorylation using the monoclonal antiphospho- Using the 5-minute timepoint where maximal labeling with the antiphosphotyrosine antibody was seen, we investigated the effect of varying concentrations of GM-CSF on the patterns of tyrosine phosphorylation in human neutrophils. An increase in phosphotyrosine labeling of the 70-and 150-Kd proteins was clearly seen with GM-CSF concentrations as low as 25 pmol/L. The intensities of these bands were noted to increase up to 100 to 200 pmol/L. The 95-Kd protein was not apparent until the GM-CSF concentration reached 100 pmol/L. The proteins at 110 to 120.54 to 56, and 44 Kd (previously reported by us to be phosphorylated on tyrosine after cell treatment with FMLP and PMA) were seen to increase their phosphotyrosine content at a slightly lower concentration of GM-CSF (5 to 10 pmol/L) (data not shown).
To gain a better understanding of the time course of tyrosine phosphorylation of neutrophil proteins by GM- 
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For To determine if the tyrosine phosphorylation of proteins seen with GM-CSF is also seen with other agonists that "prime" the neutrophil, we treated neutrophils with GM-CSF, G-CSF, or tumor necrosis factor (TNF) and then evaluated the labeling of proteins with the antiphosphotyrosine antibody. It can be seen in Fig 4 that neither G To evaluate the subcellular location of the three unique GM-CSF-inducible phosphotyrosine containing proteins, neutrophils were fractionated into cytosolic and particulate components after treatment with GM-CSF, as described in Materials and Methods. Figure 5 shows the results from a representative experiment in which neutrophils were treated with 200 pmol/L of GM-CSF for 5 minutes. In this figure it is clearly shown that the 150-Kd phosphotyrosine-containing protein induced after GM-CSF treatment (uppermost arrowhead) is localized to the 50,OOOg particulate fraction. The 95-Kd phosphotyrosine-containing protein is seen primarily within the cell cytosol (middle arrowhead). Although the tyrosine phosphorylation of the 70-Kd protein is only minimally increased in this experiment, it can be seen to be localized within both the cell cytosol and particulate fraction (lower arrowhead). Of note is that the 44-Kd phosphotyrosine-containing protein was localized to the For personal use only. on October 22, 2017. by guest www.bloodjournal.org From cytosol, as has been seen previously in neutrophils treated with FMLP or PMA. At the same time, the 110-to 120-Kd phosphotyrosine-containing protein noted after both GM-CSF and FMLP treatment is primarily particulate when GM-CSF is the agonist, whereas after FMLP treatment this phosphotyrosine-containing protein was localized within both the cytosol and particulate compartments?
A particulate location for a protein can indicate that the protein is either membrane-associated or associated with other structures related to the membrane such as the cytoskeleton. In other cell systems, phosphotyrosinecontaining proteins have been found to be associated with the cell cytoskeleton or cytoskeletal elements. We evaluated this by treating neutrophils with GM-CSF and isolating the TICS and the TSS, as described in Materials and Methods, and evaluating the phosphotyrosine-containing proteins. Figure 6 shows a photograph of a representative autoradiograph of phosphotyrosine-containing proteins in the TICS and TSS found after treatment of the cells with GM-CSF, FMLP, PMA, or control buffer. It can be seen that the 150-Kd phosphotyrosine-containing protein induced by GM-CSF is localized to the TICS. We have shown that the tyrosine kinase inhibitor ST638 inhibits neutrophil tyrosine kinase activity in vitro! Therefore, it was of interest to determine the effect of ST638 on the tyrosine phosphorylation induced by GM-CSF. We found that when neutrophils were treated with 25 Fmol/L ST638, a concentration which we found to inhibit neutrophil tyrosine kinase activity? for 10 minutes before treatment with GM-CSF, that the tyrosine phosphorylation of 150-, 95, and 70-Kd proteins was inhibited (Fig 7) .
To evaluate the role of interactions of different protein kinases in the tyrosine phosphorylation of neutrophil proteins by GM-CSF, we assessed the effect of the putative C-kinase inhibitors H-7 (1 x mol/L) and staurosporine (1 x lo-' ~o I / L )~' -~ dn the tyrosine phosphorylation patterns seen with GM-CSF. When incubation with the inhibitors was for 10 to 15 minutes before the addition of GM-CSF (200 pmol/L) for 5 minutes, no effect of H-7 on the tyrosine phosphorylation patterns was seen (arrowheads indicate the position of the 150-, 95-, and 70-Kd proteins). However, staurosporine inhibited the tyrosine phosphorylation of the 150-, 110-to 120-, 95-,7@, 54-, and 44-Kd proteins noted above (Fig 7) . To confirm this result we incubated neutrophils with to mol/L of staurosporine for 10 minutes before treatment with control buffer C or GM-CSF. Staurosporine induced a dosedependent inhibition of the GM-CSF-induced tyrosine phosphorylation of the 150-, 95, 70-, 54-, and 44-Kd proteins, being most marked at concentrations of staurosporine greater than mol/L (data not shown).
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The inhibition of GM-CSF-induced tyrosine phosphorylation by staurosporine in intact neutrophils suggests that staurosporine may inhibit a tyrosine kinase activity involved in tyrosine phosphorylation by GM-CSF, or that interaction between C-kinase and a tyrosine kinase must occur to induce the tyrosine phosphorylation. To evaluate the effect of staurosporine on tyrosine kinases, neutrophil cytosol and 50,OOOg particulate fractions from untreated cells were isolated and the in vitro tyrosine kinase activity from these isolated cell fractions was determined in the presence of varying concentrations of staurosporine. Figure 8 shows that when staurosporine is added to the tyrosine kinase reaction mixture described in Materials and Methods, the ability of neutrophil cytosol and particulate protein to phosphorylate the g1utamine:tyrosine copolymer is inhibited in a dose-dependent manner. A similar effect was seen when either crude or partially purified fractions were used for the determination of the tyrosine kinase activity. For comparison, the effect of varying concentrations of the C-kinase inhibitor H-7 on these tyrosine kinase activities is shown. It is noted that H-7 has no effect on the ability of the cytosol or particulate fraction to phosphorylate the glutamine:tyrosine copolymer.
DISCUSSION
Protein phosphorylation is a posttranslational modification of proteins that is currently felt to be responsible for the initiation of a wide variety of cellular events, including activation of neutrophils, lymphocytes, and platelets and the growth and proliferation of ~e l l s .~~-~~ Proteins can be phosphorylated on serine, threonine, or tyrosine residues by a growing number of protein kinase^?^-^^ Phosphotyrosine-containing proteins usually constitute less than 1% of total cellular phosphoproteins? Because of this, phosphorylation of proteins on tyrosine is an attractive model
Cytosol
Particulate for the regulation of cellular events. Tyrosine phosphorylation has been thought to be the primary mechanism of action of a variety of growth factor receptors and viral oncogene products that regulate cell growth, proliferation, and the malignant transformation of cells. 37 We have previously described that nonproliferative human neutrophils contain tyrosine kinase activity in both the cell cytosol and particulate fraction, and that activation of the neutrophil by the chemotactic peptide FMLP, the phorbol ester PMA, the calcium ionophore A23187, or leukotriene B4 induces the phosphorylation of specific neutrophil proteins on tyrosine residues? GM-CSF is a hematopoietic growth factor that is involved in the proliferation and differentiation of blood cells.11 In proliferating factor-dependent cell lines, GM-CSF (and interleukin-3 [IL-31) induced tyrosine phosphorylation of a number of distinct cytoplasmic proteins, including proteins of 150, 93, 70, 63, 55, 42, and 36 Kd.22 These proteins were not phosphorylated on tyrosine when the cells were treated with (TNF), G-CSF, IL-1, and IL-4, indicating that the tyrosine phosphorylation of these proteins was specific for this agonistJ2 In the present study we show, using a monoclonal antibody to phosphotyrosine, that GM-CSF induces the tyrosine phosphorylation of proteins with approximate molecular weights of 150, 110, 95, 85, 70, 54, and 44 Kd from mature nonproliferative human neutrophils. In particular, the phosphotyrosinecontaining proteins of 150, 95, and 70 Kd appear to be unique to neutrophils stimulated by GM-CSF and are not present in neutrophils treated with FMLP, PMA, G-CSF, or TNF. The similarity in the proteins phosphorylated on tyrosine by GM-CSF in the M07E cell line and the mature neutrophils may indicate that they are important to the mechanism of action of this cytokine.
GM-CSF is a "priming" agonist for neutrophils. Neutrophils can also be primed by G-CSF and TNF.38,39 However, these agonists did not induce the tyrosine phosphorylation of the 150-, 9 5 , or 70-Kd neutrophil proteins under the conditions tested in our study. The action of the GM-CSF on these proteins, therefore, in this regard, is not a result of being in the general class of neutrophil "priming" agonists, but is unique to GM-CSF.
The three unique phosphotyrosine-containing proteins induced in the neutrophil by GM-CSF showed a very rapid increase in tyrosine phosphorylation within 15 to 30 seconds, and remained phosphorylated on tyrosine through 30 minutes of treatment, with subsequent dephosphorylation after that time. This time course is interesting as the priming effect of GM-CSF on the neutrophil oxidative burst was best noted only after at least 30 to 60 minutes of incubation with GM-CSF. 13, 19, 20 This indicates that the tyrosine phosphorylation of neutrophil proteins precedes the time at which priming is seen, a requirement if tyrosine phosphorylation of a protein is required for this event.
Similarly, the tyrosine phosphorylation of neutrophil proteins by GM-CSF was dependent on a similar concentration range of the mediator as is seen for priming of the oxidative burst.*O The partitioning of phosphotyrosine-containing proteins within the cell can suggest the site of activity of the protein. Therefore, it was of interest to find that the GM-CSFFor personal use only. on October 22, 2017. by guest www.bloodjournal.org From induced 150-Kd phosphotyrosine-containing protein was exclusively localized to the particulate fraction of the neutrophil and the 95-Kd phosphotyrosine protein localized to the cytosolic fraction of the cell. As noted, the 70-Kd protein was distributed within both fractions. Although the identity of these substrates for tyrosine kinases within the neutrophil is unknown, knowing their location may help to indicate function.
The high-speed particulate fraction of the neutrophil as isolated in this study includes cell membranes, granules, other small organelles and the membrane-associated cytoskeleton. Several phosphotyrosine-containing proteins from other cell systems have been found to be associated with the cell cytoskeleton, at focal adhesion pointsa Treating the cell with Triton X-100 as described in Materials and Methods, solubilizes many integral membrane proteins and sediments an operationally defined Triton X-100 insoluble cytoskeleton after high-speed centrifugation. This fraction would also contain nuclei and proteins associated with the nucleus. The data presented in Fig 6 show that the 150-Kd phosphotyrosine-containing protein was localized to the TICS after treatment of the neutrophil with GM-CSF. The 70-Kd protein was predominantly within the TICS but can also be seen within the Tritonsoluble supernatant. The 95-Kd GM-CSF-inducible phosphotyrosine-containing protein was not distinctly seen in this experiment. This indicates that at least some (150 and 70 Kd) of the GM-CSF-inducible phosphotyrosine-containing proteins in the neutrophil are associated with the Triton X-100 insoluble cytoskeleton, and could be involved in cytoskeletal function or assembly of protein complexes in association with cytoskeletal proteins. The possibility of a nuclear location for some of these proteins must also be considered, but is considered unlikely in that these same proteins appear in the fractions shown in Fig 5 that had nuclei removed. The protein of 44-to 46-Kd phosphorylated tyrosine on stimulation with GM-CSF was localized to the cytosol in Fig 5. However, in Fig 6, although the predominant tyrosine phosphorylated protein in the GM-CSF lanes is localized to the TSS, as would be expected, a band of this size is also seen within the TICS. This apparent discrepancy was reproducible and could represent some carryover after removing the TSS from the TIC pellet, or could represent a protein that is associated with the nucleus which would be present in the TICS as prepared in this study.
Human neutrophil activation has been thought to be related to the activation of the calcium-and phospholipiddependent protein kinase It was of extreme interest that the putative C-kinase inhibitor staurosporine inhibited the GM-CSF-induced protein tyrosine phosphorylation in a concentration-dependent fashion. This result could be an effect of an interaction of kinases, where C-kinase activity is necessary for the subsequent activation of the tyrosine kinase which phosphorylates the proteins on tyrosine residues, or that the staurosporine inhibits the tyrosine kinase. This latter possibility was suggested by our finding that the C-kinase inhibitor H-7, at concentrations that we have shown to inhibit phorbol ester induced oxidative burst:' did not inhibit the GM-CSF-induced tyrosine phosphorylation. This was further suggested by our finding that staurosporine inhibited neutrophil cytosolic and particulate tyrosine protein kinase activity in an in vitro system, whereas H-7 had no effect on this activity. Although this data cannot be taken as definitive evidence that staurosporine inhibits the specific (and as yet unknown) neutrophil tyrosine kinase responsible for the GM-CSF-induced tyrosine phosphorylation, it does indicate that staurosporine does inhibit neutrophil tyrosine kinases as reported for tyrosine kinase activities from other cell lines and corroborates the recent findings of Badwey et a141 showing the inhibition of neutrophil tyrosine kinases by staurosporine. These findings emphasize that reported effects of staurosporine on neutrophil function must be interpreted with c a~t i o n .~* ,~~ Gomez-Cambronero et alZ3xz4 have previously reported that GM-CSF induces the tyrosine phosphorylation of several neutrophil proteins, as detected using a polyclonal antiphosphotyrosine a n t i b~d y .~~,~~ In their study the most prominent changes were seen in proteins of 118-, 92-, 78-, 54-, and 40-Kd proteins. No mention is made of a 150-or 70-Kd protein, which were two of the unique proteins phosphorylated on tyrosine found in our study. It is likely that the 95-Kd phosphotyrosine-containing protein induced by GM-CSF seen in our study is the same as the 92-Kd protein identified by Gomez-Cambronero et al, although lack of subcellular localization studies, timed course studies, and dose-response studies in the report of GomezCambronero et a1 prevent complete comparisons. The differences seen between their study and ours could be a result of different specificities between the polyclonal and monoclonal antibodies. However, the patterns of GM-CSFinduced tyrosine phosphorylation and the inhibition of the phosphorylation by the tyrosine kinase inhibitor, Erbstatin, as recently reported in neutrophils by McColl et a1,44 are very similar to what we have seen and support our findings.
At this time the identity of the tyrosine-phosphorylated proteins seen in human neutrophils treated with GM-CSF is unknown and any suggestion of their function is purely speculative. The finding thqt at least three of these proteins are not phosphorylated on tyrosine with the chemotactic peptide FMLP, the phorbol ester PMA, or with other agonists such as TNF or G-CSF which "prime" neutrophil functions, suggests that these may be involved in the unique activities of GM-CSF in the neutrophil. For personal use only. on October 22, 2017. by guest www.bloodjournal.org From
